To assess the correlation of ANRIL expression with clinicopathologic data, according to the relative ANRIL expression in tumor tissues, the 120 GC patients were classified into two groups: relative high group (n=55, fold change ≥ 3) and relative low group (n=65, fold change ≤ 3) (Figure 1B). The gene discussed is CDKN2B-AS1; the disease is neoplasm.